LENSAR Inc (NASDAQ: LNSR) is a Healthcare company (Medical - Devices) with a market capitalization of $60M. The Maz Rating grades it against the other companies in its sector.
LENSAR Inc's current Maz Rating and its five factor grades are for members: log in to see them.
At $4.91, LENSAR Inc trades at 4.2x trailing earnings, 1.0x sales and 5.6x book value, with an EV/EBITDA of 1.4. Over the last twelve months it generated about $59M of revenue and $14M of net income. It runs a gross margin of 52.0%, an operating margin of -3.3% and a net margin of 56.1%. It shows return on equity of 549.4%, return on invested capital of -4.1% and a free cash flow yield of -7.9%. On the balance sheet: a debt-to-equity ratio of 0.20 and a current ratio of 2.25. Over the past 52 weeks the share price ranged from $4.30 to $12.94, with a beta of 1.03.
LENSAR Inc does not currently pay a dividend.
3 Wall Street analyst ratings cover the stock: 2 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.